Ratings by Goldman Sachs (Madhu Kumar)
Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
6/9/2023 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
5/23/2023 | Cerevel Therapeutics | CERE | Maintain | Neutral (N/A) |
|
Details | ||
5/22/2023 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
5/9/2023 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
5/5/2023 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
5/4/2023 | Fulcrum Therapeutics | FULC | Downgrade | Neutral (Buy) |
2.76 (9.44) |
242.03% | Details | |
5/4/2023 | Design Therapeutics Inc | DSGN | Upgrade | Neutral (Sell) |
6.83 (4.03) |
-41% | Details | |
5/3/2023 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
4/14/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
3/29/2023 | Arcturus Therapeutics | ARCT | Maintain | Sell (N/A) |
|
Details | ||
3/13/2023 | Fulcrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
3/10/2023 | Fulcrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
3/3/2023 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
3/2/2023 | Jazz Pharmaceuticals | JAZZ | Maintain | Sell (N/A) |
|
Details | ||
3/2/2023 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
3/1/2023 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
3/1/2023 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
2/28/2023 | Krystal Biotech | KRYS | Upgrade | Buy (Neutral) |
78.46 (98.34) |
25.34% | Details | |
2/24/2023 | Dynavax Technologies | DVAX | Maintain | Buy (N/A) |
|
Details | ||
2/23/2023 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
2/22/2023 | Cerevel Therapeutics | CERE | Maintain | Neutral (N/A) |
|
Details | ||
12/8/2022 | Jazz Pharmaceuticals | JAZZ | Upgrade | Buy (Neutral) |
151.10 (120.42) |
-20.3% | Details | |
12/8/2022 | Iovanace Biotherapeutics | IOVA | Downgrade | Neutral (Buy) |
7.26 (4.40) |
-39.39% | Details | |
11/29/2022 | Cincor Pharma Inc | CINC | Maintain | Buy (N/A) |
|
Details | ||
11/29/2022 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
11/28/2022 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
11/17/2022 | Editas Medicine | EDIT | Maintain | Sell (N/A) |
|
Details | ||
11/15/2022 | Fulcrum Therapeutics | FULC | New Coverage | Buy (N/A) |
7.14 (9.44) |
32.21% | Details | |
11/10/2022 | Arcturus Therapeutics | ARCT | Maintain | Sell (N/A) |
|
Details | ||
11/10/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Neutral (N/A) |
|
Details | ||
11/8/2022 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
11/7/2022 | Krystal Biotech | KRYS | Maintain | Neutral (N/A) |
|
Details | ||
11/4/2022 | Dynavax Technologies | DVAX | Maintain | Buy (N/A) |
|
Details | ||
11/3/2022 | Cincor Pharma Inc | CINC | Maintain | Buy (N/A) |
|
Details | ||
10/28/2022 | Cincor Pharma Inc | CINC | New Coverage | Buy (N/A) |
33.97 (29.06) |
-14.45% | Details | |
10/17/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
9/29/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Neutral (Neutral) |
|
Details | ||
9/20/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Neutral (N/A) |
|
Details | ||
9/20/2022 | Cerevel Therapeutics | CERE | Maintain | Neutral (N/A) |
|
Details | ||
9/6/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
8/25/2022 | Edgewise Therapeutics | EWTX | Downgrade | Sell (Neutral) |
10.80 (18.24) |
68.89% | Details | |
8/25/2022 | Magenta Therapeutics | MGTA | Downgrade | Neutral (Buy) |
1.75 (0.70) |
-60% | Details | |
8/25/2022 | Krystal Biotech | KRYS | Downgrade | Neutral (Buy) |
76.34 (177.93) |
133.08% | Details | |
8/9/2022 | Tricida | TCDA | Maintain | Buy (N/A) |
|
Details | ||
8/9/2022 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
8/9/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
8/8/2022 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
8/8/2022 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
8/8/2022 | Myovant Sciences Ltd. | MYOV | Maintain | Neutral (N/A) |
|
Details | ||
8/8/2022 | Arrowhead Pharma | ARWR | Maintain | Buy (Buy) |
|
Details | ||
8/5/2022 | Dynavax Technologies | DVAX | Maintain | Buy (N/A) |
|
Details | ||
8/5/2022 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
8/3/2022 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
7/28/2022 | Myovant Sciences Ltd. | MYOV | Maintain | Neutral (N/A) |
|
Details | ||
7/19/2022 | Tricida | TCDA | Maintain | Buy (N/A) |
|
Details | ||
7/7/2022 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
7/1/2022 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
6/7/2022 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
5/17/2022 | Magenta Therapeutics | MGTA | Maintain | Buy (N/A) |
|
Details | ||
5/11/2022 | Edgewise Therapeutics | EWTX | Maintain | Neutral (N/A) |
|
Details | ||
5/10/2022 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
5/9/2022 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
5/5/2022 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
5/5/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Neutral (N/A) |
|
Details | ||
5/5/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
5/4/2022 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
4/13/2022 | Tricida | TCDA | New Coverage | Buy (N/A) |
9.64 (0.11) |
-98.86% | Details | |
4/13/2022 | Alector Inc. | ALEC | New Coverage | Sell (N/A) |
12.28 (6.02) |
-50.98% | Details | |
4/6/2022 | Jazz Pharmaceuticals | JAZZ | Downgrade | Neutral (Buy) |
160.73 (151.10) |
-5.99% | Details | |
3/24/2022 | Reata Pharmaceuticals | RETA | New Coverage | Buy (N/A) |
37.09 (172.36) |
364.71% | Details | |
3/15/2022 | Design Therapeutics Inc | DSGN | Maintain | Sell (N/A) |
|
Details | ||
3/8/2022 | Magenta Therapeutics | MGTA | Maintain | Buy (N/A) |
|
Details | ||
3/3/2022 | Passage Bio Inc. | PASG | Maintain | Neutral (N/A) |
|
Details | ||
3/2/2022 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
3/2/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
3/1/2022 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
3/1/2022 | Cerevel Therapeutics | CERE | Maintain | (Neutral) |
|
Details | ||
3/1/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
3/1/2022 | Arcturus Therapeutics | ARCT | Maintain | Sell (N/A) |
|
Details | ||
3/1/2022 | Dynavax Technologies | DVAX | Maintain | Buy (N/A) |
|
Details | ||
2/28/2022 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
2/28/2022 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
2/25/2022 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
2/24/2022 | Editas Medicine | EDIT | Maintain | Sell (N/A) |
|
Details | ||
2/15/2022 | Cerevel Therapeutics | CERE | New Coverage | Neutral (N/A) |
30.63 (42.27) |
38% | Details | |
2/15/2022 | Syndax Pharmaceuticals | SNDX | New Coverage | Buy (N/A) |
14.98 (23.80) |
58.88% | Details | |
1/28/2022 | Edgewise Therapeutics | EWTX | New Coverage | Neutral (N/A) |
14.00 (18.24) |
30.29% | Details | |
1/28/2022 | Cytokinetics | CYTK | New Coverage | Buy (N/A) |
30.24 (35.85) |
18.55% | Details | |
1/19/2022 | Arrowhead Pharma | ARWR | New Coverage | Buy (N/A) |
57.81 (28.60) |
-50.53% | Details | |
1/19/2022 | Passage Bio Inc. | PASG | New Coverage | Neutral (N/A) |
5.76 (1.35) |
-76.56% | Details | |
1/19/2022 | TCR2 Therapeutics | TCRR | New Coverage | Neutral (N/A) |
4.01 (1.48) |
-63.09% | Details | |
1/19/2022 | Design Therapeutics Inc | DSGN | New Coverage | Sell (N/A) |
15.85 (4.03) |
-74.57% | Details | |
1/19/2022 | Arvinas Inc. | ARVN | New Coverage | Buy (N/A) |
67.42 (41.28) |
-38.77% | Details | |
1/6/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
1/6/2022 | Dynavax Technologies | DVAX | New Coverage | Buy (N/A) |
13.40 (12.41) |
-7.39% | Details | |
1/6/2022 | Magenta Therapeutics | MGTA | Upgrade | Buy (Neutral) |
4.77 (0.70) |
-85.32% | Details | |
11/29/2021 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
11/19/2021 | Jazz Pharmaceuticals | JAZZ | New Coverage | Buy (N/A) |
133.09 (120.42) |
-9.52% | Details | |
11/19/2021 | Horizon Therapeutics | HZNP | Upgrade | Buy (Neutral) |
108.08 (116.30) |
7.61% | Details | |
11/12/2021 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
11/10/2021 | Dicerna Pharmaceuticals | DRNA | Maintain | Neutral (N/A) |
|
Details | ||
11/9/2021 | Arcturus Therapeutics | ARCT | Maintain | Sell (N/A) |
|
Details | ||
11/5/2021 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
10/27/2021 | Myovant Sciences Ltd. | MYOV | Maintain | Neutral (N/A) |
|
Details | ||
9/13/2021 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
8/27/2021 | Applied Therapeutics | APLT | Downgrade | Sell (Neutral) |
17.44 (6.80) |
-61.01% | Details | |
8/20/2021 | Myovant Sciences Ltd. | MYOV | New Coverage | Neutral (N/A) |
20.97 (26.98) |
28.66% | Details | |
8/20/2021 | Magenta Therapeutics | MGTA | New Coverage | Neutral (N/A) |
6.16 (4.77) |
-22.56% | Details | |
8/11/2021 | Dicerna Pharmaceuticals | DRNA | Downgrade | Neutral (Buy) |
23.83 (38.22) |
60.39% | Details | |
8/11/2021 | Arcturus Therapeutics | ARCT | Downgrade | Sell (Neutral) |
48.24 (33.77) |
-30% | Details | |
8/10/2021 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
8/6/2021 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
8/6/2021 | Dynavax Technologies | DVAX | New Coverage | Buy (N/A) |
9.88 (13.40) |
35.63% | Details | |
7/20/2021 | Krystal Biotech | KRYS | Upgrade | Buy (Neutral) |
61.09 (177.93) |
191.26% | Details | |
6/25/2021 | Arcturus Therapeutics | ARCT | New Coverage | Neutral (N/A) |
34.03 (33.77) |
-0.76% | Details | |
6/25/2021 | Applied Therapeutics | APLT | New Coverage | Neutral (N/A) |
25.04 (17.44) |
-30.35% | Details | |
5/21/2021 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
5/19/2021 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (Buy) |
|
Details | ||
5/17/2021 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
5/13/2021 | Editas Medicine | EDIT | Maintain | Sell (N/A) |
|
Details | ||
5/10/2021 | Krystal Biotech | KRYS | Maintain | Neutral (N/A) |
|
Details | ||
4/16/2021 | Editas Medicine | EDIT | New Coverage | Sell (N/A) |
41.53 (7.42) |
-82.13% | Details | |
4/16/2021 | Iovanace Biotherapeutics | IOVA | New Coverage | Buy (N/A) |
29.99 (7.26) |
-75.79% | Details | |
4/16/2021 | Dicerna Pharmaceuticals | DRNA | New Coverage | Buy (N/A) |
27.83 (38.22) |
37.33% | Details | |
4/16/2021 | Apellis Pharmaceuticals | APLS | New Coverage | Buy (N/A) |
44.48 (46.99) |
5.64% | Details |